April 4 (Reuters) - Biopharmx Corp BPMX.A
* Health canada approves biopharmx corporation study of
violet iodine
* Engages kgk synergize, inc. To manage its canadian phase 4
study for violet molecular iodine breast health supplement
Source text for Eikon: ID:nCNWmR695a
Further company coverage: BPMX.A
(Bengaluru Newsroom: +1 646 223 8780)